Market cap is now around $23 B. It is within the range to be taken over by one of the big drug firms. But they probably won't bite because for the most part they consider VRTX a one drug company.
Leiden sat on his #$%$ too long concentrating on CF and neglecting to move other compounds forward at a reasonable speed. So now we do not have any non-CF drug near completion of phase 3 and on top of that other companies are racing to develop CF drugs and possibly create another Incivek fiasco.
Yesterday 5.7 M shares were traded and VRTX closed at 96.37. The average daily volume is 1.7M.
One wonders who were these sellers? Hedge funds/short sellers? Mutual funds trying to raise cash for redemption of panicked customers? Panicked individual investors?
It would be interesting to know the answer but I guess there is no way to find the answer.
Never take any advice from the Motley Fools website, especially for the stocks recommended by the owners of Motley Fools-- the Gardener brothers. I got suckered into DDD when they were still hyping it at its high pps and am sitting on a big loss. Motley Fools and Gardener brothers simply suck!
"Which we’ve written about quite a few times — to their credit, the Motley Fool was the first one of the big newsletter publishers to get on board this 3D printing trend and push it hard as an investing theme back in March, calling it the “end of ‘Made in China'”, but it’s also been teased by Nicholas Vardy and Michael Robinson in recent months. Heck, I even got on board back in June and profiled DDD and their main competitor, Stratasys (SSYS) for the Irregulars.
And yes, DDD has gone up quite nicely since the Foolies started recommending it early this year. If the teaser ad is accurate on the dates (they aren’t always), then Gardner picked this one four months and 26 days before August 14, so that would mean he recommended it on February 17th (which is indeed the “third Friday” of the month, the day the newsletter typically publishes). From the chart I would have guessed February 22, since that’s the day there was a huge spike in the trading volume (it traded 10X as many shares) and a jump in price by about 10%, but either way it means he picked the stock right around $20. Right now it’s just shy of $40, so a 94% gain sound about right. "
Below is the date, closing price and volume.
Dec 16, 2015 245,000 23.59
Dec 15, 2015 496,200 24.86
Dec 14, 2015 202,900 26.98
Dec 11, 2015 349,800 27.68
Dec 10, 2015 292,000 30.15
Dec 9, 2015 439,500 30.53
Dec 8, 2015 386,200 30.75
Dec 7, 2015 724,900 31.37
Dec 4, 2015 1,367,200 31.13
Dec 3, 2015 924,700 29.32
Dec 2, 2015 646,800 30.97
Dec 1, 2015 1,280,600 34.19
Nov 30, 2015 2,550,100 32.78
Nov 27, 2015 4,335,200 34.83
Nov 25, 2015 8,616,500 26.63
Nov 24, 2015 6,323,000 18.40
Nov 23, 2015 17,036,800 39.50
Nov 20, 2015 13,198,400 18.25
Nov 19, 2015 12,529,300 10.40
Nov 18, 2015 7,057,200 2.07
Those who followed a hated person like Shkreli deserve what is coming to them when and if the stock ever trades again.
Martin Shkreli was arrested on Securities Fraud Charges this morning on charges that he plundered the company that he was with before and was fired from. Apparently, he liquidated a lot of that company's assets to pay off for his trade losses. I will not be surprised if the #$%$ had a lot of losses when he was shorting NKTR like crazy.
is killing just about all biotech stocks. Whenever there is bad news for any biotech stock the traders and hedge funds go to to work. It seems it is happening much more often that it used to. I am assuming they make money doing that or they wont be doing it.
What I do not understand is how they cover their shorts without getting killed since some of these stocks drop several dollars one day and go up several dollars the next day.